Bristol Myers Squibb is buying an Nvidia DGX SuperPOD powered by the Vera Rubin architecture. The pharmaceutical giant is the first life sciences company to acquire the upcoming hardware to accelerate its drug discovery and development operations. This deal highlights the expanding enterprise footprint of high-performance AI hardware beyond traditional tech sectors into biotech.
Opening Kapyn…